Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gilead Sciences, Inc. (GILD) vs Grab Holdings Ltd. (GRAB) Price & Performance

Gilead Sciences, Inc.Trade
Grab Holdings Ltd.Trade

Price performance (Past 24H)

Key statistics

Gilead Sciences, Inc. vs Grab Holdings Ltd. — how do they compare? Gilead Sciences, Inc. trades at $135.19 (market cap $168.35B), while Grab Holdings Ltd. trades at $3.74 (market cap $15.26B). The key difference: Gilead Sciences, Inc. is far larger — about 11× Grab Holdings Ltd.'s market cap, and Gilead Sciences, Inc. pays a 2.42% dividend while Grab Holdings Ltd. pays none. Which is the better fit depends on your goals.

GILDGRAB
Market Cap
$168.35B$15.26B
Sector
HealthTechnology
52-Week High
$155.80$6.45
52-Week Low
$110.56$3.27
Enterprise Value
$191.42B$10.99B
Dividend Yield
2.42%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Gilead Sciences, Inc.

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.

Read more on GILD

About Grab Holdings Ltd.

Grab Holdings Limited operates as a holding company. The Company, through its subsidiaries, develops delivery management, mobility, financial services, and enterprise software solutions. Grab Holdings serves customers worldwide.

Read more on GRAB